PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 3, 2026Drug and Alcohol Review4 citationsOpen Access

Higher THC Concentration Medicinal Cannabis Products Efficacy and Safety Considerations: A Rapid Review

View Full Paper
MGMyfanwy GrahamDADereje Zewdu AssefaNCNgo Cong‐Lem

Key Points

  • The central aim is to assess the safety and efficacy of medicinal cannabis products containing high THC concentrations above 22%.
  • Conducted a rapid review of available literature
  • Analyzed products classified under Category 5
  • Focused on THC concentrations above 22% w/w
  • No evidence found regarding the safety of high THC cannabis products
  • No evidence found regarding the efficacy of these products

Abstract

No evidence was found on safety or efficacy of prescribed Category 5 medicinal cannabis products with THC concentrations above 22% w/w (220 mg/g).

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Graham et al. (2026) studied this question.

synapsesocial.com/papers/69cf5f505a333a821460e57fhttps://doi.org/10.1111/dar.70145
Ask AI
Helpful
Bookmark
Share
View Full Paper